Granules Pharma gets USFDA nod for genetic disorder drug Colchicine Medical Dialogues Bureau8 Feb 2020 10:30 AM IST "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a...
Lupin posts net loss at Rs 835 crore in Q3 Medical Dialogues Bureau8 Feb 2020 10:15 AM ISTNew Delhi: Pharma firm Lupin on Thursday reported widening of its consolidated net loss to Rs 835 crore for the quarter ended December 2019 on account...
AbbVie gets positive CHMP Opinion for VENCLYXTO for Leukemia patients Medical Dialogues Bureau8 Feb 2020 10:00 AM ISTNew Delhi: AbbVie , a research-based global biopharmaceutical company, announced recently that the Committee for Medicinal Products for Human Use...
GSK India to sell Vemgal facility Medical Dialogues Bureau8 Feb 2020 9:30 AM IST As part of this strategic review, GSK India will explore future options for the Vemgal facility including a potential sale of the site, it added. ...
Capping Trade Margins of pharma would save Rs 984 crore, Ashwini Kumar Choubey informs LS Farhat Nasim7 Feb 2020 4:53 PM ISTThere would be an annual saving of approx. Rs. 984 crores to the patients under 'Trade margin Rationalisation Approach' by the National Pharmaceutical...
Sun Pharma reports Rs 6923.40 crore total expenses in Q3 Farhat Nasim7 Feb 2020 4:43 PM ISTNew Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore...
Strides Pharma arm inks pact with Pharmaceutics International to acquire 18 ANDA Farhat Nasim7 Feb 2020 3:34 PM IST "Strides...announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has entered into a definitive asset...
Regeneron partners with US to develop treatment for coronavirus Medical Dialogues Bureau7 Feb 2020 9:30 AM ISTUS: The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has...
Merck to spin-off biosimilar drugs business to focus on Keytruda Medical Dialogues Bureau7 Feb 2020 9:15 AM IST Merck will retain its cancer drugs, including blockbuster cancer therapy Keytruda, vaccines, hospital and animal health businesses, the company...
Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament Farhat Nasim6 Feb 2020 4:43 PM ISTNPPA has detected and issued about 162 demand notices against the pharmaceutical companies for overcharging consumers on the sale of Anti-diabetic and...
Lupin gets USFDA nod for generic version of Arava Tablets Medical Dialogues Bureau6 Feb 2020 1:08 PM IST Leflunomide Tablets USP is a generic equivalent of Arava Tablets, 10 mg and 20 mg, of Sanofi- Aventis, Lupin said.Mumbai: Pharma major Lupin Limited...
Granules India sells entire stake in JV Biocause Pharma Medical Dialogues Bureau6 Feb 2020 1:00 PM ISTNew Delhi: Drugmaker Granules India Ltd recently said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a...
